Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

8
Sensex ends mildly higher amid volatile moves, Nifty above 10,850-mark; pharma gains big

2018-06-13 moneycontrol
Some selling pressure gripped the market in the last hour of trade as investors may have turned cautious ahead of US Federal Reserve’s policy meet decision later in the day.
PGDQY PAGEIND RCOM RUCHISOYA 532827 IDEA ICLQY 500368 532712 500493 532822 BHARATFORG

0
Page Industries hits record high

2018-06-13 thehindubusinessline
Shares of Page Industries Ltd jumped as much as 6.5 per cent to their all-time high of Rs 26,320. The stock posted its biggest intraday percentage gain since May 25.
PGDQY PAGEIND 532827

0
Page Industries Limited - Updates

2018-06-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PGDQY PAGEIND 532827

33
Closing Bell: Sensex rises 262 pts, Nifty above 10,600; Brent crude below $77/bbl, rupee up 60 paise

2018-05-27 moneycontrol
Rupee Closing: The Indian rupee continued its recovery for the second consecutive session after hitting 18-month low of 68.42 against the US dollar on Wednesday. It ended at 67.78 a dollar, up 56 paise from previous close.
523405 ESL PAGEIND 533096 IDBI MS.PRE 533273 MS.PRF TCHQY MS.PRG 532978 MS.PRA 532755 534742 CADILAHC 532321 500470 5225 MS 500570 IHHHF TATAMOTORS JMFINANCIL PGDQY 500116 532827 533264 ZUARI 532843 532622 CDLYY TECHM OBZIY BAJAJFINSV TTST MS.PRI OBEROIRLTY TATASTEEL FORTIS TATLY GDL MS.PRK ADANIPOWER Q0F TTM

46
Bulls roar: Sensex gains 261 pts; Nifty Midcap up 360 pts amid sharp gains in rupee, fall in oil

2018-05-27 moneycontrol
Bulls retained charge at Dalal Street for the second consecutive session on Friday as the Sensex gained more than 300 points intraday. The rally was driven by banking & financials, auto, metals, oil and pharma stocks.
PAGEIND 590003 BHUSANSTL TCHQY 532755 CADILAHC 535789 532321 GSCLCEMENT 534816 BJJQY 500570 EICHERMOT CLNDY 500055 PGDQY 532827 YYBKY 518029 TECHM BAJAJFINSV BAJFINANCE TATASTEEL TATLY 500180 KOTAKBANK COALINDIA BHRYY IDBI 532978 533278 505200 500470 INFRATEL HDFCBANK TATAMOTORS 500034 YESBANK ECQRY 500116 KMBKY IBN IDKQY 532648 CDLYY IBULHSGFIN ICICIBANK TTST HDB 532174 500247 KARURVYSYA TTM

0
Page Industries gains 5% on strong March quarter numbers

2018-05-27 moneycontrol
Shares of Page Industries added 5.3 percent intraday Friday on the back of strong March quarter numbers.
PGDQY PAGEIND 532827

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

9h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...